HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutilating palmoplantar keratoderma successfully treated with etretinate.

Abstract
Three patients, a mother and her two sons, with mutilating palmoplantar keratoderma (Vohwinkel's syndrome) were successfully treated with oral etretinate (Tigason). All of them had keratotic constriction furrows of one or more digits (pseudo-ainhum) with threatening spontaneous amputation. Oral treatment with etretinate brought about disappearance of the pseudo-ainhums and normalization of the digital blood circulation. The hyperkeratotic skin became thinned and pliable with a dose-dependent trend towards redness and atrophy. Continued long term etretinate medication has made it possible for these patients to fulfill their social and occupational activities. All 3 patients had acoustic impairment of high-pitched tone perception.
AuthorsK Wereide
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 64 Issue 6 Pg. 566-9 ( 1984) ISSN: 0001-5555 [Print] Sweden
PMID6084939 (Publication Type: Journal Article)
Chemical References
  • Etretinate
Topics
  • Adolescent
  • Adult
  • Etretinate (therapeutic use)
  • Female
  • Fingers (pathology)
  • Hearing Loss, High-Frequency (etiology)
  • Humans
  • Keratoderma, Palmoplantar (drug therapy, genetics, pathology)
  • Male
  • Middle Aged
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: